Text Size

Pulse Spectrum Analysis in Adult Asthmatics: Correlation With Lung Function, Asthma Control Exhaled Nitric Oxide and Metabolites in Exhaled Breath Condensate

This study is not yet open for participant recruitment.
Verified October 2012 by National Taiwan University Hospital
Sponsor:
Information provided by (Responsible Party):
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01719393
First received: October 30, 2012
Last updated: October 31, 2012
Last verified: October 2012
History of Changes
  Purpose

Our hypothesis is that radial arterial pulse may reflect the severity and airway function in asthmatics. The aims of this study are to investigate the pulse spectrim of the radial artery in adult asthmatics, and evaluate its correlation with airy inflammation an lung funtion in asthmatics.


Condition
Pulse Spectrum Analysis
Pulmonary Function
FeNO
Metabolites

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Pulse Spectrum Analysis in Adult Asthmatics: Correlation With Lung Function, Asthma Control Exhaled Nitric Oxide and Metabolites in Exhaled Breath

Resource links provided by NLM:

MedlinePlus related topics: Asthma
U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:
  • Pulse spectral analysis [ Time Frame: one year ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

Exhaled brath condensate


Estimated Enrollment: 100
Study Start Date: November 2012
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)
Detailed Description:

The microcirculation is directly involved in the cellular matabolism and homeostasis. Our hypothesis is that radial arterial pulse spectrum may reflect the airway condition in asthmatics. The aims of this study are to investigate the pulse spectrim of the radial artery in adult asthmatics, and evaluate its correlation with lung function, asthma control status,exhaled nitric oxide, and metabolites in the exhaed breath condensates.

  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Asthma paitients

Criteria

Inclusion Criteria:

  • Meet the diagnostic criteria of GINA guideline asthma patients

Exclusion Criteria:

  • Cancer or immune impaired patients;
  • pack-year smoking> 5;
  • long-term ventilator-dependent patients
  • Control group: 30 age matched healthy controls
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01719393

Contacts
Contact: Ping-Hung Kuo 886-2-23123456 ext 63075 kph712@ntuh.gov.tw

Locations
Taiwan
National Taiwan University Hospital Not yet recruiting
Taipei, Taiwan
Contact: Ping-Hung Kuo     886-2-23123456 ext 63075     kph712@ntuh.gov.tw    
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: Ping-Hung Kuo National Taiwan University Hospital
  More Information

No publications provided

Responsible Party: National Taiwan University Hospital, M.D.
ClinicalTrials.gov Identifier: NCT01719393     History of Changes
Other Study ID Numbers: 201207062RIC
Study First Received: October 30, 2012
Last Updated: October 31, 2012
Health Authority: Taiwan: National Taiwan University Hospital

Keywords provided by National Taiwan University Hospital:
Asthma
Pulse spectrum analysis
lung function
 exhaled nitric oxide
metabolites
exhaled breath condensate

Additional relevant MeSH terms:
Nitric Oxide
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
Anti-Asthmatic Agents
Respiratory System Agents
Therapeutic Uses
 Free Radical Scavengers
Antioxidants
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Endothelium-Dependent Relaxing Factors
Vasodilator Agents
Cardiovascular Agents
Protective Agents

ClinicalTrials.gov processed this record on May 22, 2013